SUMMARY Cartilage link protein of high purity was prepared and used in an enzyme linked immunosorbent assay (ELISA). Antibodies to link protein were sought in the sera of 98 patients with rheumatic disorders; 38 with rheumatoid arthritis (RA), 29 with osteoarthritis (OA), 13 with psoriatic arthritis (PA), nine with ankylosing spondylitis (AS), nine with systemic lupus erythematosus (SLE), and in 83 healthy controls. Antibodies were detected in all groups with the following prevalences: 21/83 normals, 9/38 RA, 7/29 OA, 7/13 PA, 3/9 AS, and 4/9 SLE. No statistically significant differences existed between the groups with regard to either prevalence or mean titre of anti-link antibodies. Serum antibodies to proteoglycan link protein appear to be no more common in patients with rheumatic disorders than in healthy controls.
transfer of either anticollagen II antibodies9 or lymphoid cells'0 or cloned T lymphocytes responsive to PG core protein" from arthritic to naive animals the recipient animals develop arthritis, suggesting that both B cell and T cell immunity are important in the development of clinical disease. Genetic factors are also important, however, as not all animals with natural or acquired immunity to cartilage components become arthritic. 6 8 Our knowledge of the degree of autoimmunity to cartilage matrix in human inflammatory arthropathy is much more fragmentary. Only a small proportion (about 3%) of patients with rheumatoid arthritis possess autoantibodies that react immunocytochemically with cartilage.'2 In patients with RA, however, the estimated incidence of antibodies to native collagen types II, IX, and XI is 10%, 2%, and 2-8% respectively,13 though the incidence of antibodies to denatured collagens is higher. '3 1 Both cell mediated and humoral immunity to cartilage PG antigens have been demonstrated in patients with rheumatoid arthritis and ankylosing spondylitis.15 16 The high incidence of anti-PG antibodies reported in patients with RA by Glant et 886 al (38%; 11/29 patients) was obtained from experiments in which proteoglycan-rich extracts of cartilage, rather than purified proteins, were used. 15 The present study describes the preparation of link protein from human articular cartilage and its use in ELISA assays to detect autoantibodies in the sera of patients Tween 20) . Unbound proteins were removed by rinsing (3 x 5 min) in PBS/0-05% Tween 20. Bound primary antibody was detected after a two hour incubation with GARS-HRP (1:3000 dilution), washing, and visualisation of HRP activity in the chromogen solution (160 ,ug/ml 3-amino-9-ethylcarbazole, 0*2 M sodium acetate, 0-1 mM H202, pH 5-2). ENZYME LINKED IMMUNOSORBENT ASSAY Ninety six well polystyrene ELISA plates (Immunoplate IF, Nunc, Denmark) were coated with 50 tl of link protein (10 ig/ml) in 1 M NaCl, 10 mM MOPS, pH 7-0 buffer. After one hour's incubation at room temperature the plates were washed three times with distilled water and exposed to 0-5% Tween/ PBS buffer (250 pl) for one hour to remove weakly adsorbed protein.
Non-specific binding sites were blocked by treatment for two hours with 0-1% w/v casein in 10 mM trometamol (TRIS)-HCl pH 7-6 buffer containing 154 mM NaCl and 0-02% thiomersal (casein buffer). Serum samples were diluted 1:20 in casein buffer, and 50 RI aliquots were added to the wells in quadruplicate. After overnight incubation at 4°C the wells were emptied and washed five times (250 Rl/wash) with casein buffer. Bound IgG antibodies were detected using biotinylated protein A and avidin-HRP conjugate. Equal volumes of biotinylated protein A (0-8 pg/ml) and avidin-HRP (6.4 [sg/ml) in casein buffer were mixed rapidly and 50 RI aliquots added to each well for four hours at room temperature. Wells were then washed five times with casein buffer. Chromogen solution (1-8 mM 2,2'-azinobis(3-ethylbenzthiazoline sulphonic acid), 0*1 mM H202 in PBS, 200 ul/well) was added and the colour developed at room temperature on a plate shaker. Absorbance at 414 nm was measured with a Bio-Rad model 2550 plate reader.
Standards of human IgG (0-100 ng/well) immobilised on the wells and blocked as described above were incorporated into each assay to relate colour development to the amount of bound IgG. Sera were classed as negative if absorbance was less than three SDs above the mean absorbance of the zero IgG standard. The Wilcoxon rank sum test and x test were used to analyse the differences in titres between disease groups and prevalence of positive samples in the different groups respectively. (Fig. lb) .
SEPHADEX G-150 SUPERFINE CHROMATOGRAPHY
Separation of the hyaluronic acid affinity purified link protein by chromatography on Sephadex G-150 SF (Fig. 2) yielded a large excluded peak (fraction 1) with a broad shoulder (fraction 2). Analysis by SDS-PAGE (Fig. 2) Table 1 shows the mean and standard deviation (SD) of the standard serum incorporated on each plate in four assays. The coefficient of intra-assay variation ranged from 4 to 12% with a mean of 7*51%. Table 2 shows mean and SD values obtained for individual serum samples related to a standard serum in a number of assays. The interassay coefficient of variation ranged from 6 to 19% with a mean of 11-4%.
The variation in antibody levels with time was examined in four normal individuals selected on the basis of their absorbance readings in preliminary assays. The results showed that within an individual the serum level of anti-link protein antibody remains essentially constant over periods of up to five weeks (Fig. 4) .
Antibodies reactive against link protein were detected in all groups (Fig. 5) . The geometric mean titre of antibodies to link protein in the control group (8-61 ng) was very close to those in the RA (8-54 ng) and OA (10.03 ng) groups, and no significant differences were observed between the control population and any disease group. Only four sera (one control, one RA, and two OA) had antibody levels more than two SDs above the Analysis of the prevalence of antibodies to link protein showed that there were no significant 
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Mean coefficient of intra-assay variation (CV) = 7-51%. = Male, *=female subjects. The fact that ELISA assays present absorbance results as a continuous variable can present problems with regard to the definition of a normal range. Antibody titres significantly above zero were found in 25% of the normal control, 24% of the RA, 24% of the OA, 54% of the PA, 33% of the AS, and 44% of the SLE groups. There were no statistically significant differences between the groups either in the prevalence, the positive response, or the mean antibody titre. On another basis of defining the normal range, only one RA, two OA, and one control sera showed antibody titres greater than two SDs above the mean positive control titre. As antibody titres greater than three SDs above the mean are absent in all patients of the RA (n=38) and OA (n=29) groups, by applying X2 goodness of fit analysis it can be shown that the incidence of high titre antibodies in all patients with RA or OA is likely (p<005) to be less than 8% and 10% respectively. The possibility that in arthritic patients excess circulating link protein arising from damaged articular cartilage causes erroneously low titres of antibody is being investigated.
Autoantibodies to a variety of antigens have been detected in normal individuals and may have a clearance role for the disposal of the products of catabolism.30 It is possible that the antibodies detected in this study and autoantibodies to degraded glycosaminoglycans and hyaluronic acid detected in preimmune rabbits29 fall into this category. An alternative possibility that structural mimicry leads to cross reaction between link protein and antibodies to foreign antigens cannot be excluded and requires -further study.
In conclusion, we describe a reproducible assay for link protein antibodies. Such antibodies appear to be present in similar proportions and titre in both healthy persons and patients with different forms of arthritis. It thus appears that antibodies to link protein are unlikely to play a major part in the 
